1

COVID-19 and the Circulatory System

Mary Dawn Bonette O. Banquerigo

BS PSYCHOLOGY II
SAINT PAUL UNIVERSITY DUMAGUETE
 2

The coronavirus family is comprised of single-stranded, positive-sense RNA viruses that are

capable of undergoing quick transformation and rearrangement. Coronaviruses are capable of causing

infections of the respiratory system as well as infections of the gastrointestinal systems in both humans

and animals. It is common knowledge that severe respiratory infections such as the common cold,

respiratory syncytial virus, and bacterial pneumonia can put a person at risk for developing cardiovascular

disease. It has been shown that complications from an underlying cardiovascular disease can increase the

occurrence of virus infections and the intensity of those infections. The authors of this study, headed by

Madjid, offer a concise introduction to coronaviruses and investigate the potential impacts that these

viruses may have on the cardiovascular system (Madjid et al., 2021). In order to better understand the

impacts of coronaviruses on the circulatory system, this study drew on lessons learned from earlier

outbreaks of SARS, Middle East respiratory syndrome, and seasonal influenza. This study was performed

to keep up with the rapid evolution of their knowledge of COVID-19. This article from a scholarly

magazine discusses the fundamentals of coronaviruses, with a particular emphasis on COVID-19, as well

as the impacts these viruses have on the cardiovascular system.

According to what is stated in the article, the virus is capable of causing viral pneumonia along

with a variety of additional extrapulmonary manifestations and complications. A significant number of

individuals present with preexisting cardiovascular conditions and risk factors for heart disease. (Sarkesh

et al., 2020). The incidence of certain diseases, such as hypertension, diabetes mellitus, cardiovascular

disease, and neurological disease, is one of the many prevalent repercussions that contribute to an

increased mortality rate. There is an increased likelihood of passing away if you are male, of mature age,

or of advanced age. The presence of elevated levels of high-sensitivity troponin, a measure of severe

myocardial injury, is frequently observed in conditions that pose a high risk of mortality and is strongly

correlated with passing away. The levels of troponin are a dependable predictor of the sort of injury that
 3

has been done (K & Chaudhuri, 2020). Antibodies and antivirals that are efficacious against SARS-CoV-2

are the subjects of intensive study and development at present. Meanwhile, coronary risk factors and

diseases must be managed carefully in line with scientifically sound guidelines.

Our knowledge and comprehension of COVID-19, as well as its detection, prevention, and

management, is continuously expanding and improving. Reading scientific works like this journal article

is something that medical practitioners are strongly encouraged to do in order to ensure that they are

always up to date on the most pertinent information. It will be essential to identify the factors that place

people infected with COVID-19 at risk for developing cardiac complications as more cases of the disease

are reported and as our comprehension of it improves. The development of a risk model for heart

problems, as well as the determination of the incidence of heart problems, will be of great assistance. This

publication plays an essential role in determining the causes of the illness and the correlations between

them.

REFERENCES

K, A. B., & Chaudhuri, D. (2020). A Review of Acute Myocardial Injury in Coronavirus Disease 2019.

Cureus. https://doi.org/10.7759/cureus.8426

Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2021). Potential Effects of Coronaviruses

on the Cardiovascular System. JAMA Cardiology, 5(7), 831.

https://doi.org/10.1001/jamacardio.2020.1286

Sarkesh, A., Sorkhabi, A. D., Sheykhsaran, E., Alinezhad, F., Mohammadzadeh, N., Hemmat, N., &

Baghi, H. B. (2020). Extrapulmonary Clinical Manifestations in COVID-19 Patients. American

Journal of Tropical Medicine and Hygiene, 103(5), 1783–1796. https://doi.org/10.4269/ajtmh.20-

0986